NEWS & EVENTS
Company News
Press Release
For Immediate Release
June 2, 2009
Contact: Gregg DiPietro
Leerink Swann
(617) 918-4601
Gregg.DiPietro@leerink.com
Contact: Risa Burgess or Justin Drake
Schwartz Communications
(781) 684-0770
Leerink@schwartz-pr.com
Leerink Swann Appoints Brent Clough as Senior Managing Director, Head of MEDACorp
Boston, MA – June 2, 2009 - Healthcare investment bank Leerink Swann announced that Brent Clough has joined the firm as Senior Managing Director, Head of MEDACorp.
Prior to joining Leerink Swann, Mr. Clough was President and CEO of IntrinsiQ, LLC., a leading source for US oncology software and data analytics. He started his career at IntrinsiQ by founding its financial arm that was created to commercialize data from IntrinsiQ Research for the financial services industry. Before IntrinsiQ, Mr. Clough worked for Goldman Sachs in its investment research and electronic trading group. Previously, he spent eight years with First Call Corporation, where he ultimately became Managing Director of the Broker Dealer division.Mr. Clough holds a Bachelor of Science degree in Finance from the University of Colorado Business School.
"I’m delighted to welcome Brent to Leerink Swann,” said Jeff Leerink, Chairman and CEO, Leerink Swann. "Brent brings an extensive and impressive set of leadership experiences in the healthcare, finance and informatics industries. Our MEDACorp network, comprised of over 30,000 experts across all areas of healthcare, is a core asset of our Firm and a critical component of our knowledge-based platform. Brent’s leadership of MEDACorp will further enhance this unique asset and enable Leerink Swann to deliver superior value to current and future clients.”
About Leerink Swann
Leerink Swann is a healthcare-focused investment banking firm that provides equity research, corporate finance, strategic advisory and asset management services for institutional, life sciences and high-net-worth clients. Every year since 2001, Institutional Investor has named Leerink Swann “Best of the Boutiques” in several healthcare categories. Through its MEDACorp division, Leerink Swann provides biomedical-consulting services to the institutional investment community. With an internal team of experts and a dedicated external network of academic and community healthcare professionals, MEDACorp assesses the viability of cutting-edge medical technologies, thus giving decision makers the information they need to perform. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.